不妊治療サービス市場レポート：不妊原因別、手技別、サービス別、エンドユーザー別、地域別、2025～2033年

世界の不妊治療サービスの市場規模は2024年に461億米ドルに達しました。IMARC Groupは、市場は2033年までに1,420億米ドルに達し、2025～2033年にかけて12.65%の成長率（CAGR）を示すと予測しています。市場を牽引する要因はいくつかありますが、不妊症患者数の増加、さまざまな不妊治療に対する個人の認識と受容の高まり、税制優遇措置など政府の好意的な取り組みなどが挙げられます。

不妊治療サービス市場の分析：

• 主な市場促進要因：世界市場は、機械学習（ML）や人工知能（AI）のような先進技術の導入により、力強い成長を遂げています。これらの技術は、過去の体外受精（IVF）サイクルの大規模なデータセットを分析することで、体外受精（IVF）サイクルの成功を予測することができます。
• 主な市場動向：不妊症患者数の増加や政府の有利な取り組みが重要な動向の一部です。
• 地理的動向：アジア太平洋地域が明確な優位性を示しており、主要企業間の様々なパートナーシップにより最大の市場シェアを占めています。
• 競合情勢：不妊治療サービス業界の主な市場参入企業は、Instituto Bernabeu Group、INVO Bioscience, Inc.、Monash IVF Group、Apollo Hospitals Enterprise Ltd.、CARE Fertility Group Ltd.、Carolinas Fertility Institute、Genea Limited、The Cooper Companies, Inc.、Virtus Health Group、Vitrolife Sweden AB、The Johns Hopkins Health System Corporation、Medicover AB（publ）、OvaScience, Inc.、Progyny, Inc.、Xytex Corporationなどです。
• 課題と機会：治療費の高騰は市場の大きな課題です。しかし、デジタルヘルスソリューションに対するニーズの高まりは、個人に合わせた治療計画への注目の高まりと相まって、こうした課題を克服し、市場機会をもたらすと予測されます。

不妊治療サービス市場の動向：

政府の積極的な取り組み

出生率を高めるため、上海では2024年5月31日に12の生殖補助医療（ART）を基本健康保険に統合しました。この取り組みにより、高額な不妊治療による不妊カップルの負担が軽減されました。各国の政府機関は、多くのサービスを提供することで、不妊問題に直面している人々にとって不妊治療をより身近で安価なものにしています。体外受精（IVF）のような不妊治療に対して、直接的な資金援助や補助金を提供しています。これにより、患者の自己負担額が減り、不妊治療サービスの需要が高まります。また、公的な不妊治療クリニックに投資することで、私立クリニックと比較して低費用で質の高い治療を提供しています。これにより、経済状況にかかわらず、より広範な人々が不妊治療サービスを利用できるようになります。さらに、不妊治療を規制・支援する法的枠組みを確立し、安全で倫理的な治療が受けられるよう、行政当局が整備を進めています。さらに、国によっては、不妊治療にかかる費用が税控除の対象となり、課税所得を減らし、経済的負担を軽減することができます。

不妊症患者の増加

世界中で不妊症の患者数が増加していることは、市場にとって好材料です。ライフスタイルの変化、環境の影響、加齢に関連した問題、医学的疾患の結果として、個人がこれらの問題に対処しています。現代の食生活では重要な栄養素が不足しており、生殖機能に悪影響を及ぼす可能性があります。現代の目まぐるしいライフスタイルでは、高レベルのストレスが蔓延しており、月経周期の乱れや精子の質の低下を引き起こす可能性があります。糖尿病や高血圧などの生活習慣病を引き起こすだけでなく、慢性的なストレスは不妊症の原因にもなります。これとは別に、キャリア志向、経済的安定、個人的目標などさまざまな理由から、子作りを遅らせることを選択する人が増えており、これが不妊治療サービス市場の洞察につながります。さらに、これらの問題を治療するのに有益な治療機器の需要が増加しています。IMARC Groupの調査報告書によると、世界の不妊治療機器市場は2032年までに7億2,950万米ドルに達すると予測されています。

様々な治療に対する認識と受容の高まり

個人における様々な不妊治療に対する認識と受容の高まりが、市場の成長を後押ししています。世界中の政府機関や非政府機関は、利用可能な治療オプションの幅広い可用性に関する個人の意識を喚起するのに有益なキャンペーンを組織しており、これが不妊治療サービスの成長を後押ししています。このようなキャンペーンは、不妊の原因や早期介入の利点に関する情報を広めるために、メディアやソーシャルプラットフォーム、地域社会への働きかけを利用することが多くあります。これに加えて、不妊の問題や体外受精、代理出産、卵子凍結の利用法について率直に語る有名人の事例が公表されることで、これらの処置につきまとうスティグマが軽減されます。その知名度によって、他の人々も他人から批判されることを心配することなく、同等の選択肢を検討するようになります。さらに、同市場の主要企業は、サービスを拡大し、不妊治療サービス市場の収益を増加させるために、大手企業間の提携や協力に取り組んでいます。例えば、2023年4月26日、柔軟な資金調達プランとコンシェルジュによるサポートサービスを備えた家族形成のための全国的なプラットフォームFuture Family（FF）と、北米で包括的な生殖サービスを提供するトッププロバイダーであるPrelude Network（R）が独占契約を締結しました。このパートナーシップは、プレミアムな不妊治療サービスへの経済的アクセスを拡大し、より多くの経済的選択肢と治療費の適切な理解を患者に与えます。FFはまた、患者が個々の治療計画に基づいて不妊治療費用を理解できるよう、パーソナライズされた支払い選択ツールを開発しました。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の不妊治療サービス市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場内訳：不妊原因別
• 市場内訳：手技別
• 市場内訳：サービス別
• 市場内訳：エンドユーザー別
• 市場内訳：地域別
• 市場予測

第6章 市場内訳：不妊原因別

• 男性不妊
• 女性不妊

第7章 市場内訳：手技別

• 体外受精（卵細胞質内精子注入法）（IVF・ICSI）
• 代理出産
• 卵細胞質内精子注入を伴わない体外受精（ICSIを伴わないIVF）
• 子宮内人工授精（IUI）
• その他

第8章 市場内訳：サービス別

• 新鮮非提供卵
• 凍結非提供卵
• 卵子・胚バンク
• 新鮮提供卵
• 凍結提供卵

第9章 市場内訳：エンドユーザー別

• 不妊治療クリニック
• 病院
• 外科センター
• 臨床研究機関
• 凍結バンク

第10章 市場内訳：地域別

• 欧州
• 北米
• アジア太平洋地域
• 中東・アフリカ
• ラテンアメリカ

第11章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第14章 価格分析

第15章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Instituto Bernabeu Group
  • INVO Bioscience, Inc.
  • Monash IVF Group
  • Apollo Hospitals Enterprise Ltd.
  • CARE Fertility Group Ltd.
  • Carolinas Fertility Institute
  • Genea Limited
  • The Cooper Companies, Inc.
  • Virtus Health Group
  • Vitrolife Sweden AB
  • The Johns Hopkins Health System Corporation
  • Medicover AB（publ）
  • OvaScience, Inc.
  • Progyny, Inc.
  • Xytex Corporation

List of Figures

• Figure 1: Global: Fertility Services Market: Major Drivers and Challenges
• Figure 2: Global: Fertility Services Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Fertility Services Market: Breakup by Cause of Infertility (in %), 2024
• Figure 4: Global: Fertility Services Market: Breakup by Procedure (in %), 2024
• Figure 5: Global: Fertility Services Market: Breakup by Service (in %), 2024
• Figure 6: Global: Fertility Services Market: Breakup by End-User (in %), 2024
• Figure 7: Global: Fertility Services Market: Breakup by Region (in %), 2024
• Figure 8: Global: Fertility Services Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 9: Global: Fertility Services Industry: SWOT Analysis
• Figure 10: Global: Fertility Services Industry: Value Chain Analysis
• Figure 11: Global: Fertility Services Industry: Porter's Five Forces Analysis
• Figure 12: Global: Fertility Services (Male Infertility) Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 13: Global: Fertility Services (Male Infertility) Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 14: Global: Fertility Services (Female Infertility) Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 15: Global: Fertility Services (Female Infertility) Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 16: Global: Fertility Services (In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)) Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 17: Global: Fertility Services (In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)) Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 18: Global: Fertility Services (Surrogacy) Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 19: Global: Fertility Services (Surrogacy) Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 20: Global: Fertility Services In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI) ) Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 21: Global: Fertility Services (In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI) ) Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 22: Global: Fertility Services (Intrauterine Insemination (IUI)) Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 23: Global: Fertility Services (Intrauterine Insemination (IUI)) Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 24: Global: Fertility Services (Other Procedures) Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 25: Global: Fertility Services (Other Procedures) Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 26: Global: Fertility Services (Fresh Non-Donor) Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 27: Global: Fertility Services (Fresh Non-Donor) Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 28: Global: Fertility Services (Frozen Non-Donor) Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 29: Global: Fertility Services (Frozen Non-Donor) Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 30: Global: Fertility Services (Egg and Embryo Banking) Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 31: Global: Fertility Services (Egg and Embryo Banking) Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 32: Global: Fertility Services (Fresh Donor) Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 33: Global: Fertility Services (Fresh Donor) Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 34: Global: Fertility Services (Frozen Donor) Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 35: Global: Fertility Services (Frozen Donor) Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 36: Global: Fertility Services (Fertility Clinics) Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 37: Global: Fertility Services (Fertility Clinics) Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 38: Global: Fertility Services (Hospitals) Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 39: Global: Fertility Services (Hospitals) Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 40: Global: Fertility Services (Surgical Centres) Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 41: Global: Fertility Services (Surgical Centres) Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 42: Global: Fertility Services (Clinical Research Institutes) Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 43: Global: Fertility Services (Clinical Research Institutes) Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 44: Global: Fertility Services (Cryobanks) Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 45: Global: Fertility Services (Cryobanks) Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 46: Europe: Fertility Services Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 47: Europe: Fertility Services Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 48: North America: Fertility Services Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 49: North America: Fertility Services Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 50: Asia Pacific: Fertility Services Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 51: Asia Pacific: Fertility Services Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 52: Middle East and Africa: Fertility Services Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 53: Middle East and Africa: Fertility Services Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 54: Latin America: Fertility Services Market: Sales Value (in Billion USD), 2019 & 2024
• Figure 55: Latin America: Fertility Services Market Forecast: Sales Value (in Billion USD), 2025-2033

List of Tables

• Table 1: Global: Fertility Services Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Fertility Services Market Forecast: Breakup by Cause of Infertility (in Billion USD), 2025-2033
• Table 3: Global: Fertility Services Market Forecast: Breakup by Procedure (in Billion USD), 2025-2033
• Table 4: Global: Fertility Services Market Forecast: Breakup by Service (in Billion USD), 2025-2033
• Table 5: Global: Fertility Services Market Forecast: Breakup by End-User (in Billion USD), 2025-2033
• Table 6: Global: Fertility Services Market Forecast: Breakup by Region (in Billion USD), 2025-2033
• Table 7: Global: Fertility Services Market: Competitive Structure
• Table 8: Global: Fertility Services Market: Key Players

The global fertility services market size reached USD 46.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 142.0 Billion by 2033, exhibiting a growth rate (CAGR) of 12.65% during 2025-2033. There are several factors that are driving the market, which include rising number of infertility cases, increasing awareness and acceptance among individuals about a variety of fertility treatments, and favorable government initiatives like tax benefits.

Fertility Services Market Analysis:

• Major Market Drivers: The global market is experiencing robust growth, driven by the introduction of advanced technologies like machine learning (ML) and artificial intelligence (AI). These technologies can predict the success of in-vitro fertilization (IVF) cycles by analyzing large datasets from previous cycles.
• Key Market Trends: The rising number of infertility cases and favorable government initiatives are some of the important trends.
• Geographical Trends: Asia Pacific exhibits a clear dominance, accounting for the biggest market share owing to various partnerships among key players.
• Competitive Landscape: Major market players in the fertility services industry are Instituto Bernabeu Group, INVO Bioscience, Inc., Monash IVF Group, Apollo Hospitals Enterprise Ltd., CARE Fertility Group Ltd., Carolinas Fertility Institute, Genea Limited, The Cooper Companies, Inc., Virtus Health Group, Vitrolife Sweden AB, The Johns Hopkins Health System Corporation, Medicover AB (publ), OvaScience, Inc., Progyny, Inc., and Xytex Corporation, among many others.
• Challenges and Opportunities: High costs of treatments is a major market challenge. Nonetheless, the increasing need for digital health solutions, coupled with the rising focus on personalized treatment plans among individuals, is projected to overcome these challenges and provide market opportunities.

Fertility Services Market Trends:

Favorable Government Initiatives

In an effort to increase the birth rate, Shanghai integrated 12 forms of assisted reproductive technology (ART) into basic health insurance on May 31, 2024. This initiative reduced infertile couples' burden from expensive fertility treatments. Government agencies of various countries are making fertility treatments more accessible and affordable for individuals facing infertility issues by providing numerous services. They are providing direct financial assistance or subsidies for fertility treatments such as in vitro fertilization (IVF). This reduces the out-of-pocket costs for patients, thereby increasing fertility services demand. They are also investing in public fertility clinics to provide high-quality care at lower costs as compared to private clinics. This ensures that a wider range of people, regardless of their financial status, can access fertility services. In addition, governing authorities are establishing legal frameworks that regulate and support fertility treatments and ensuring that they are safe, ethical, and accessible. Furthermore, in some countries, the costs associated with fertility treatments may be tax-deductible, allowing individuals to reduce their taxable income and lessen the financial burden of these services.

Increasing Number of Infertility Cases

The growing number of infertility cases among the masses across the globe is offering a favorable fertility services market outlook. Individuals are dealing with these problems as a result of changing lifestyles, environmental influences, age-related problems, and medical ailments. Modern diets are deficient in vital nutrients, which can be harmful to reproductive health. In today's fast-paced lifestyle, high levels of stress are prevalent and can cause menstrual cycle disruption and sperm quality reduction. In addition to causing lifestyle disorders like diabetes and hypertension, chronic stress also causes infertility issues. Apart from this, the rising number of people are choosing to delay parenthood for various reasons including career aspirations, financial stability, and personal goals, which provide fertility services market insights. Furthermore, there is an increase in the demand for treatment devices that are beneficial in treating these issues among individuals. As per the research report of the IMARC Group, the global infertility treatment devices market is expected to reach US$ 729.5 Million by 2032.

Rising Awareness and Acceptance About a Variety of Treatment

The increasing awareness and acceptance of various fertility treatments among individuals is propelling the market growth. Governing agencies and non-governmental agencies around the world are organizing campaigns that benefit in generating awareness among individuals about the wide availability of treatment options available, which is bolstering the fertility services growth. These campaigns often use media, social platforms, and community outreach to disseminate information about the causes of infertility and the benefits of early intervention. Besides this, publicized instances involving celebrities who candidly talk about their infertility issues and usage of IVF, surrogacy, or egg freezing help to lessen the stigma attached to these procedures. Its visibility inspires others to investigate comparable choices without worrying about being judged by others. Furthermore, major companies in the market are engaging in partnerships and collaborations among major players to expand their services and increase fertility services market revenue. For instance, on 26 April 2023, a nationwide platform for family-building with flexible financing plans and concierge support services 'Future Family (FF)' and Prelude Network(R), a top provider of all-inclusive reproductive services in North America, established an exclusive agreement. The partnership will expand financial accessibility to premium fertility services and empower patients with more financial options and a proper understanding of treatment costs. FF also developed a personalized payment choice tool that allows patients to understand fertility costs based on their individual treatment plans.

Fertility Services Market Segmentation:

Breakup by Cause of Infertility:

• Male Infertility
• Female Infertility

Male infertility accounts for the majority of the market share

Male infertility issues can result from a number of factors including bad eating and poor exercise habits. Treatments like intracytoplasmic sperm injection (ICSI), in which a single sperm is injected straight into an egg, are becoming common, especially when it comes to low sperm counts or motility problems. Several medications and hormonal therapies are available to address specific causes of male infertility like hormonal imbalances or infections. These treatments are effective in providing a viable solution to male infertility.

Breakup by Procedure:

• In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
• Surrogacy
• In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI)
• Intrauterine Insemination (IUI)
• Others

In vitro fertilization with intracytoplasmic sperm injection (IVF with ICSI) holds the largest share of the industry

In vitro fertilization with intracytoplasmic sperm injection (IVF with ICSI) is beneficial in cases of severe male infertility, where traditional IVF methods might not be as effective. It is used to maximize the chances of fertilization among individuals. The growing demand for effective treatments like IVF with ICSI, as people are seeking assisted reproductive technologies (ART) to overcome infertility, is offering a favorable fertility services industry outlook.

Breakup by Service:

• Fresh Non-Donor
• Frozen Non-Donor
• Egg and Embryo Banking
• Fresh Donor
• Frozen Donor

Frozen non-donor represents the leading market segment

Frozen non-donor services include the use of frozen eggs or embryos from the intended mother or parents, without the involvement of donors. The preference for frozen non-donor services is likely driven by advancements in cryopreservation techniques, offering higher success rates and flexibility for patients in terms of timing their fertility treatments. Advancements in egg freezing techniques like vitrification are leading to higher survival rates of eggs during the freezing and thawing processes. This makes frozen eggs a more viable option for future fertility treatments and shows fertility services market dynamics.

Breakup by End-User:

• Fertility Clinics
• Hospitals
• Surgical Centres
• Clinical Research Institutes
• Cryobanks

Fertility clinics exhibit a clear dominance in the market

Fertility clinics offer a wide range of treatments like IVF, ICSI, egg and sperm donation, fertility preservation, and genetic testing. Their ability to provide a full spectrum of services under one roof makes them the go-to option for patients. These clinics often provide personalized treatment plans tailored to the specific needs of each patient, which increases the chances of patient satisfaction. Fertility services market highlights that fertility clinics are focusing on expanding their reach and establishing networks of clinics in various regions, making their services more accessible to a broader population. In addition, these clinics are staffed with experts in reproductive medicine including fertility specialists, embryologists, and genetic counselors, ensuring high-quality care. They are also equipped with the latest technology and lab facilities, which are crucial for performing advanced procedures.

Breakup by Region:

• Europe
• North America
• Asia Pacific
• Middle East and Africa
• Latin America

Asia Pacific leads the market, accounting for the largest fertility services market share

The report has also provided a comprehensive analysis of all the major regional markets, which include Europe, North America, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, Asia Pacific represents the largest regional market for fertility services.

Asia Pacific is home to some of the world's most populous countries such as China and India. With a large population, the number of people facing infertility is significant, driving the demand for fertility services. Urbanization, changing lifestyles, delayed marriages, and increasing age of first-time parents are contributing to rising infertility rates among individuals in the region. Moreover, fertility services industry report demonstrates that environmental factors such as pollution and exposure to toxins, play a crucial role. Besides this, governing authorities in the region are encouraging treatment solutions related to infertility. For instance, in 2024, government agencies in Maharashtra launched in-vitro fertilization (IVF) centers in some selected government-run medical colleges and hospitals (GMCH) to provide free treatment to thousands of couples grappling with infertility. The move was made in response to the alarming drop in Maharashtra's total fertility rate (TFR).

Competitive Landscape:

• The fertility services market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the fertility services industry include Instituto Bernabeu Group, INVO Bioscience, Inc., Monash IVF Group, Apollo Hospitals Enterprise Ltd., CARE Fertility Group Ltd., Carolinas Fertility Institute, Genea Limited, The Cooper Companies, Inc., Virtus Health Group, Vitrolife Sweden AB, The Johns Hopkins Health System Corporation, Medicover AB (publ), OvaScience, Inc., Progyny, Inc., Xytex Corporation, etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

• Key players in the market are expanding their range of services to include not just basic fertility treatments but also advanced technologies like preimplantation genetic testing (PGT), fertility preservation (egg or sperm freezing), and third-party reproduction (egg or sperm donation and surrogacy). They are also expanding their footprint by opening new fertility clinics in emerging markets. Furthermore, companies are engaging in strategic partnerships and acquisitions to strengthen their market presence. For example, on 25 April 2023, Cryoport, Inc., a leading global provider of innovative temperature-controlled supply chain solutions for the life sciences, reproductive medicine and animal health industries, announced that it signed a 3-year agreement with Boston IVF, a one of the world's most experienced fertility treatment providers.

Key Questions Answered in This Report

• 1.What was the size of the global fertility services market in 2024?
• 2.What is the expected growth rate of the global fertility services market during 2025-2033?
• 3.What has been the impact of COVID-19 on the global fertility services market?
• 4.What are the key factors driving the global fertility services market?
• 5.What is the breakup of the global fertility services market based on the cause of infertility?
• 6.What is the breakup of the global fertility services market based on the procedure?
• 7.What is the breakup of the global fertility services market based on the service?
• 8.What is the breakup of the global fertility services market based on the end-user?
• 9.What are the key regions in the global fertility services market?
• 10.Who are the key players/companies in the global fertility services market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Fertility Services Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Cause of Infertility
• 5.5 Market Breakup by Procedure
• 5.6 Market Breakup by Service
• 5.7 Market Breakup by End-User
• 5.8 Market Breakup by Region
• 5.9 Market Forecast

6 Market Breakup by Cause of Infertility

• 6.1 Male Infertility
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Female Infertility
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Procedure

• 7.1 In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Surrogacy
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI)
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Intrauterine Insemination (IUI)
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Service

• 8.1 Fresh Non-Donor
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Frozen Non-Donor
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Egg and Embryo Banking
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Fresh Donor
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Frozen Donor
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by End-User

• 9.1 Fertility Clinics
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Hospitals
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Surgical Centres
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Clinical Research Institutes
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Cryobanks
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast

10 Market Breakup by Region

• 10.1 Europe
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 North America
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Asia Pacific
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast
• 10.4 Middle East and Africa
  • 10.4.1 Market Trends
  • 10.4.2 Market Forecast
• 10.5 Latin America
  • 10.5.1 Market Trends
  • 10.5.2 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Instituto Bernabeu Group
  • 15.3.2 INVO Bioscience, Inc.
  • 15.3.3 Monash IVF Group
  • 15.3.4 Apollo Hospitals Enterprise Ltd.
  • 15.3.5 CARE Fertility Group Ltd.
  • 15.3.6 Carolinas Fertility Institute
  • 15.3.7 Genea Limited
  • 15.3.8 The Cooper Companies, Inc.
  • 15.3.9 Virtus Health Group
  • 15.3.10 Vitrolife Sweden AB
  • 15.3.11 The Johns Hopkins Health System Corporation
  • 15.3.12 Medicover AB (publ)
  • 15.3.13 OvaScience, Inc.
  • 15.3.14 Progyny, Inc.
  • 15.3.15 Xytex Corporation